Willis Investment Counsel

Position in ABBV — AbbVie Inc.

CIK 1310929 GAINESVILLE, GA

Position in ABBV

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$257,679

+$48,019 QoQ

Shares Held

1,024

+6.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#3,773

of 4,167 holders

Holding Since

Mar 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Willis Investment Counsel holds $210,142,319 across 6 Drug Manufacturers - General names. ABBV ranks #6 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	309,486	$78,600,159
2	PFE	Pfizer Inc	1,818,508	$43,789,672
3	MRK	Merck & Co., Inc.	312,767	$40,190,559
4	SNY	Sanofi	602,300	$25,694,118
5	LLY	ELI LILLY & Co	18,017	$21,610,132
6	ABBV	AbbVie Inc. This page	1,024	$257,679

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$257,679	1,024	+6.2%	Shares	Sole	2026-08-03
2026-03-31	$209,660	964	-9.4%	Shares	Sole	2026-05-05
2025-12-31	$243,113	1,064	-10.5%	Shares	Sole	2026-01-22
2025-09-30	$275,301	1,189	+4.2%	Shares	Sole	2025-11-05
2025-06-30	$211,792	1,141	0.0%	Shares	Sole	2025-08-12
2025-03-31	$239,062	1,141	-1.1%	Shares	Sole	2025-04-16
2024-12-31	$205,065	1,154	+1.1%	Shares	Sole	2025-01-24
2024-09-30	$225,324	1,141	0.0%	Shares	Sole	2024-10-11
2024-03-31	$207,776	1,141	-11.8%	Shares	Sole	2024-04-24
2023-03-31	$206,224	1,294	—	Shares	Sole	2024-03-07
No filing history on record for this holder in this stock.